Development of a Dual-Cross-Linked Collagen-Based Bioink for High-Resolution 3D Bioprinting and Antiaging.
Abstract
The advancement of personalized antiaging therapies demands the convergence of biomaterial innovation and precision fabrication technologies. Here, we present the development of a dual-cross-linked collagen-based bioink, integrating methacrylated collagen (CMA) and 1,4-butanediol diglycidyl ether (BDDE), tailored for DLP-based bioprinting. BDDE functions as a chemical cross-linker by forming stable ether bonds with hydroxyl groups on the collagen backbone, thereby reinforcing the structural integrity of the matrix. Subsequent photo-cross-linking of CMA generates an interpenetrating network that imparts superior enhancements to mechanical resilience, proteolytic endurance, and structural robustness. Bioink supports high-resolution cell-laden printing and enables the fabrication of geometrically complex, high-fidelity constructs. Moreover, the incorporation of bioactive retinol (VA) allows for the fabrication of functionalized hydrogel facial patches with targeted antiaging activity.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims to develop a dual-cross-linked collagen-based bioink that supports high-resolution 3D bioprinting for antiaging applications. The relevance lies in its focus on creating biomaterials that could potentially address aspects of aging through innovative therapeutic applications.
Author of this paper? Send a correction.